Not Yet Recruiting INTERVENTIONAL NCT06137365

Cannabis for Obesity Trial

A Randomized, Placebo-Controlled Clinical Trial of Once Daily Oral Cannabis for Weight Loss in Obese Individuals

Sponsor: Joshua A. Lile, Ph.D.

Conditions Obesity

Updated 10 times since 2023 Last updated: Apr 13, 2026 Started: Jun 21, 2026 Primary completion: Mar 31, 2028 Completion: Mar 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Obesity, this trial is actively recruiting participants. The trial is conducted by Joshua A. Lile, Ph.D. and has accumulated 10 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Apr 18, 2026 — Present [daily]

Not Yet Recruiting

Phase: PHASE2 → None
Feb 2026 — Apr 2026 [monthly]

Not Yet Recruiting PHASE2
Oct 2025 — Feb 2026 [monthly]

Not Yet Recruiting PHASE2
Jul 2025 — Oct 2025 [monthly]

Not Yet Recruiting PHASE2
Apr 2025 — Jul 2025 [monthly]

Not Yet Recruiting PHASE2

▶ Show 5 earlier versions

Jan 2025 — Apr 2025 [monthly]

Not Yet Recruiting PHASE2
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2
Apr 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE2
Dec 2023 — Apr 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

The goal of this study is to determine the initial efficacy of once daily oral cannabis for weight loss in obese individuals.

Contact Information

Sponsor contact:

Joshua A. Lile, Ph.D.

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.